GO:0006955 immune response: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006955 (immune response) is defined as any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
• Immune responses are initiated by recognition of microorganisms or danger signals and then activate coordinated cellular and humoral effector programs.
• The immune response is central to vaccine efficacy, host defense against influenza and pneumonia, cancer immunosurveillance, and neuroinflammation after traumatic brain injury.
• Metabolic reprogramming of immune cells and extracellular vesicle signaling are now recognized as core regulatory layers of immune response.
• Key genes and proteins include pattern-recognition receptors, cytokines, chemokines, antigen-presentation molecules, and immune checkpoint regulators.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of immune response genes in human cell systems.
Description
GO:0006955, immune response, is the biological process through which an organism detects and reacts to potential internal or invasive threats. It encompasses the initial recognition of microorganisms, the activation of innate and adaptive immune cells, and the effector mechanisms that eliminate or contain the threat. Because immune response is calibrated rather than all-or-none, its intensity, duration, and specificity determine whether host defense succeeds or whether immunopathology develops. The term is therefore a central organizing concept in immunology, vaccinology, oncology, and infectious disease research. Researchers study immune response to understand how vaccines generate protection, how tumors evade immune control, and how dysregulated inflammation contributes to tissue injury. In cancer, metabolic reprogramming of immune cells shapes antitumor immunity and immunotherapy response. In infectious disease, the host immune response to influenza A virus and to pneumonia involves integrated pulmonary and systemic circuits. In neurobiology, immune response after traumatic brain injury drives secondary injury and repair. Extracellular vesicles add another layer by transferring immune signals between cells. Together, these studies show that immune response is not a single pathway but a network of recognition, signaling, and effector modules that can be modeled experimentally with CRISPR-based human cell systems.
immune response At A Glance
| GO ID | GO:0006955 |
|---|---|
| GO term | immune response |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| Major function | Detection of and response to internal or invasive threats through innate and adaptive immune mechanisms. |
| Representative triggers | Microorganisms, danger signals, altered self, and tissue damage. |
| Representative mediators | Cytokines, chemokines, pattern-recognition receptors, antigen-presentation molecules, and extracellular vesicles. |
| Disease relevance | Cancer, influenza, pneumonia, traumatic brain injury, and vaccine response. |
What Is GO:0006955?
According to the Gene Ontology, GO:0006955 immune response is any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. In practical terms, this includes the molecular and cellular events by which the host senses danger, transduces signals, recruits and activates immune cells, and resolves or sustains the response. The definition emphasizes calibration, meaning the response is tuned in magnitude and duration rather than being a fixed switch. It also emphasizes threat detection, which can be triggered by microbial molecules, damaged cells, or altered self. The term is a biological process and is therefore used to annotate gene products that participate in any stage of host defense, from recognition to effector function to regulation.
Why Is immune response Important in Cell Biology?
Immune response is important because it determines outcomes across infectious disease, vaccination, cancer, and tissue injury. Vaccines work by inducing a calibrated immune response that provides protection upon later exposure. In influenza A virus infection, the balance between viral control and immunopathology depends on host immune response dynamics. In pneumonia, integrated pulmonary immune responses determine clearance and lung injury. In cancer, immune response mechanisms underlie immunosurveillance and the success or failure of immunotherapy. Metabolic reprogramming of immune cells further modulates these outcomes. In traumatic brain injury, immune response contributes to secondary damage and repair. Extracellular vesicles mediate intercellular immune communication and can amplify or dampen responses. Because of this breadth, immune response is a high-value target for mechanistic studies and therapeutic intervention.
• Vaccine design depends on inducing protective immune response.
• Host defense against influenza A virus requires coordinated immune response.
• Pulmonary immune response determines outcomes in pneumonia.
• Cancer immunosurveillance and immunotherapy rely on immune response mechanisms.
• Metabolic reprogramming of immune cells shapes immune response in cancer.
• Extracellular vesicles transfer immune signals and regulate immune response.
• Traumatic brain injury triggers immune response that affects neurological outcome.
• Recognition of microorganisms is the initiating step of immune response.
• Dysregulated immune response can cause immunopathology rather than protection.
• CRISPR models allow causal testing of immune response genes in human cells.
What Happens During immune response?
Recognition of microorganisms and danger signals
In simple terms: The immune system first has to notice that something is wrong.
Immune response begins with recognition of microorganisms or internal danger signals by host receptors. This recognition step converts a threat into intracellular signaling that activates immune programs. Recognition is calibrated so that the response matches the type and magnitude of the threat. In cancer, recognition of tumor-derived signals contributes to immune activation or tolerance. In traumatic brain injury, damage-associated signals initiate immune response in the central nervous system.
Activation of innate immune signaling
In simple terms: Once danger is detected, fast-acting innate signals mobilize the first line of defense.
After recognition, innate immune signaling pathways activate effector cells and produce cytokines and chemokines. Chemokines direct immune cell migration to sites of threat. In the lung, integrated innate and adaptive circuits coordinate the pulmonary immune response to pneumonia. In influenza A virus infection, innate signaling shapes both viral control and inflammation. Extracellular vesicles can also carry immune signals that modulate innate activation.
Antigen presentation and adaptive immune activation
In simple terms: The immune system shows pieces of the threat to specialized cells so that a precise response can be made.
Adaptive immune response requires antigen presentation and activation of T and B cells. This step links innate recognition to antigen-specific immunity. Vaccines exploit this process by delivering antigens with signals that promote durable adaptive immune response. In cancer, antigen presentation influences whether tumors are recognized and eliminated. In pneumonia, adaptive immune activation contributes to pathogen clearance and resolution.
Effector mechanisms and pathogen clearance
In simple terms: Activated immune cells then attack and remove the threat.
Effector mechanisms include cytokine-mediated killing, antibody responses, and cytotoxic activity that eliminate or contain the threat. In influenza A virus infection, effector immune responses reduce viral burden but can also contribute to tissue damage. In pneumonia, effector responses in the lung determine clearance and recovery. In cancer, effector immune cells can kill tumor cells, but tumors may evade these mechanisms. Extracellular vesicles can modulate effector functions by transferring signals between immune cells.
Resolution, memory, and calibration
In simple terms: After the threat is controlled, the immune system winds down and remembers the encounter.
Resolution and memory are essential parts of calibrated immune response. Vaccination induces memory so that subsequent exposure triggers a faster and stronger response. In traumatic brain injury, failure to resolve immune response can lead to chronic neuroinflammation. In cancer, chronic unresolved immune response can promote tumor progression or immune exhaustion. Metabolic reprogramming of immune cells influences resolution and memory formation.
Key Genes Involved in GO:0006955 immune response
The following genes and proteins represent major functional classes within GO:0006955 immune response, including recognition, signaling, antigen presentation, effector function, and regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Pattern-recognition receptor for microbial molecules | Innate immune response initiation |
| MYD88 | Adaptor in innate immune signaling | Signal transduction downstream of recognition |
| NFKB1 | Transcription factor in immune activation | Inflammatory gene expression |
| IL6 | Cytokine in immune response | Inflammation and host defense |
| TNF | Cytokine in immune response | Inflammatory signaling and pathology |
| CCL2 | Chemokine recruiting immune cells | Immune cell migration in cancer and infection |
| CXCL10 | Chemokine recruiting T cells | Th1 immune response and cancer immunity |
| IFNG | Cytokine activating immune effector functions | Antiviral and antitumor immunity |
| HLA-A | Antigen presentation to CD8 T cells | Adaptive immune recognition |
| HLA-DRA | Antigen presentation to CD4 T cells | Adaptive immune activation |
| CD8A | T cell co-receptor for cytotoxic responses | Effector T cell function |
| CD4 | T cell co-receptor for helper responses | Adaptive immune coordination |
| PDCD1 | Immune checkpoint receptor | T cell exhaustion and immunotherapy |
| CD274 | Immune checkpoint ligand | Tumor immune evasion |
| GZMB | Cytotoxic granule protease | Effector killing by immune cells |
| PRF1 | Pore-forming protein in cytotoxic granules | Cytotoxic effector function |
| CD14 | Co-receptor for microbial recognition | Innate immune sensing |
| LYZ | Antimicrobial enzyme | Effector innate immunity |
How Is immune response Regulated?
Immune response is regulated at multiple levels, including recognition thresholds, cytokine and chemokine networks, checkpoint molecules, and metabolic state. Chemokines control the spatial and temporal recruitment of immune cells, thereby shaping the intensity of the response. Immune checkpoints such as PDCD1 and CD274 restrain T cell activity and are central to cancer immune evasion. Metabolic reprogramming of immune cells modulates their activation, differentiation, and effector function. Extracellular vesicles provide an additional regulatory layer by transferring immune-modulatory cargo between cells. In the lung, integrated regulatory circuits balance pathogen clearance and tissue protection during pneumonia. In traumatic brain injury, regulatory failure can lead to persistent neuroinflammation. Vaccination exploits regulation by combining antigen with adjuvants that tune the magnitude and quality of the response.
immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDCD1 | Cancer immune evasion and immunotherapy response | Knockout in T cells or cancer cell co-culture |
| CD274 | Tumor immune evasion | Overexpression in tumor cells and T cell killing assays |
| IFNG | Antiviral and antitumor immunity | Knockout in immune cells and infection models |
| CCL2 | Cancer and inflammation | Knockout in myeloid cells and migration assays |
| HLA-A | Antigen presentation and cancer immunity | Point mutation or knockout in antigen-presenting cells |
Cancer and immune evasion
Immune response is critical for cancer immunosurveillance, and tumors often evade immune control by altering antigen presentation, checkpoint signaling, and chemokine networks. Metabolic reprogramming of immune cells in the tumor microenvironment further suppresses antitumor immunity. Extracellular vesicles released by tumors can modulate immune response and promote evasion. These mechanisms are central to immunotherapy resistance and are active areas of CRISPR-based target discovery.
Influenza and pneumonia
Host immune response to influenza A virus determines both viral clearance and the extent of lung injury. In pneumonia, integrated pulmonary immune responses coordinate pathogen elimination and resolution of inflammation. Dysregulated immune response can lead to severe disease, making these pathways important for therapeutic and vaccine development.
Traumatic brain injury and neuroinflammation
After traumatic brain injury, immune response contributes to secondary injury and repair. Persistent or poorly calibrated neuroinflammation can worsen neurological outcomes. Understanding immune response in the central nervous system is therefore a priority for neuroprotective strategies.
Vaccine response and infectious disease control
Vaccines work by inducing a calibrated immune response that provides protection against subsequent infection. The principles of vaccine delivery and immune response basics are foundational for developing new vaccines against emerging pathogens. Immune response mechanisms also inform the design of therapies for infectious diseases such as influenza and pneumonia.
From immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for immune response? | CRISPR knockout in primary immune cells or cell lines |
| Does a specific variant alter immune signaling? | Point-mutation knock-in at the endogenous locus |
| How does a fusion or tag affect immune protein function? | Knock-in of tagged allele |
| Does overexpression of a gene drive immune activation? | Overexpression cell model |
| Which genes regulate immune evasion in cancer? | CRISPR library screening in co-culture systems |
| What pathways are altered in immune response? | Transcriptomic and bioinformatic analysis after perturbation |
How to Study the immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Immune response profiling in infection and cancer |
| Multiplex cytokine assay | Cytokine and chemokine levels | Quantifying immune signaling output |
| Flow cytometry | Immune cell subsets and activation | Phenotyping immune response in tissues |
| Extracellular vesicle isolation | Vesicle cargo and function | Intercellular immune communication |
| CRISPR knockout screening | Gene requirement for immune phenotypes | Target discovery in immune cells |
| Phospho-proteomics | Signaling pathway activation | Mapping innate immune signaling |
| Antigen presentation assay | T cell activation by antigen-presenting cells | Adaptive immune response studies |
| In vivo infection model | Host immune response and pathogen control | Influenza and pneumonia research |
Transcriptomic profiling of immune response
RNA sequencing measures global gene expression changes during immune response and can identify pathways activated by infection, vaccination, or tumor challenge. In cancer, transcriptomic profiling reveals metabolic and immune signatures associated with response or resistance. In traumatic brain injury models, RNA-seq can define neuroinflammatory programs.
Cytokine and chemokine profiling
Cytokine and chemokine measurements quantify the signaling output of immune response. Chemokine profiling is particularly informative for understanding immune cell recruitment in cancer and infection. Multiplex assays allow simultaneous measurement of many mediators in serum, tissue, or supernatant.
Flow cytometry and immune cell phenotyping
Flow cytometry identifies and quantifies immune cell subsets, activation markers, and effector molecules during immune response. It is widely used to assess T cell activation, exhaustion, and cytotoxicity in cancer and infection models. In lung infection models, flow cytometry characterizes pulmonary immune cell infiltration.
Extracellular vesicle analysis
Extracellular vesicles can be isolated and characterized to study their role in immune response. Their cargo and functional effects on immune cells can be tested in vitro and in vivo. This method adds a layer of intercellular communication to immune response studies.
How CRISPR Can Be Used to Study GO:0006955 immune response
Knockout
CRISPR knockout is used to delete immune response genes and test their requirement for recognition, signaling, and effector function. For example, knocking out chemokine genes can reveal their role in immune cell recruitment. Knockout of checkpoint genes can enhance T cell activity in cancer models.
Point Mutation
Point-mutation knock-in allows modeling of disease-associated variants in immune response genes. This approach can test whether a specific amino acid change alters signaling, antigen presentation, or cytokine production. It is particularly useful for validating variants identified in cancer or infectious disease studies.
Knock-in
Knock-in of tags, reporters, or fusion proteins enables visualization and biochemical analysis of immune response proteins at endogenous levels. Tagged knock-in can be used to track protein localization during immune activation. Knock-in of human immune genes into model systems can facilitate translational studies.
Overexpression
Overexpression models test whether increased levels of an immune response gene are sufficient to drive activation or evasion. Overexpression of checkpoint ligands such as CD274 can suppress T cell killing in cancer models. Overexpression of cytokines or chemokines can amplify immune signaling in vitro.
How EDITGENE Supports immune response Research
Researchers studying immune response-related genes often need to determine whether a candidate gene is causally involved in recognition, signaling, or effector function. EDITGENE provides CRISPR-based cell model services that enable precise perturbation of immune response genes in relevant human cell types.
Contact EDITGENE today to design your custom CRISPR model for immune response research.
Frequently Asked Questions About immune response
What is GO:0006955 immune response?
GO:0006955 is the Gene Ontology biological process defined as any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
What genes are involved in immune response?
Genes involved in immune response include pattern-recognition receptors such as TLR4, signaling adaptors such as MYD88, cytokines such as IL6 and TNF, chemokines such as CCL2 and CXCL10, antigen-presentation genes such as HLA-A and HLA-DRA, and checkpoint genes such as PDCD1 and CD274.
How is immune response activated?
Immune response is activated by recognition of microorganisms or danger signals, followed by innate signaling, antigen presentation, and effector mechanisms.
What is the role of chemokines in immune response?
Chemokines direct the migration of immune cells to sites of threat and shape the composition of the immune response in cancer and infection.
How does immune response relate to cancer?
Immune response is critical for cancer immunosurveillance, and tumors evade it through mechanisms such as checkpoint signaling and metabolic reprogramming.
What is the host immune response to influenza?
The host immune response to influenza A virus involves recognition, innate signaling, adaptive activation, and effector mechanisms that control virus but can also cause lung injury.
How is immune response studied in the laboratory?
Immune response is studied using RNA-seq, cytokine assays, flow cytometry, extracellular vesicle analysis, and CRISPR-based perturbation.
What is the pulmonary immune response to pneumonia?
The pulmonary immune response to pneumonia is an integrated set of innate and adaptive mechanisms that clear pathogens and resolve inflammation in the lung.
Can CRISPR be used to study immune response genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of immune response genes in human cells.
What is the role of extracellular vesicles in immune response?
Extracellular vesicles transfer immune-modulatory cargo between cells and can amplify or dampen immune response.
Conclusion
GO:0006955 immune response is a foundational biological process that integrates recognition, signaling, antigen presentation, effector function, and resolution. Its dysregulation contributes to cancer, infectious disease, and neuroinflammation, making it a central target for mechanistic and therapeutic research. CRISPR-based cell models provide a powerful approach to dissect the causal roles of immune response genes and to accelerate the development of new interventions.
References
- 1. Xia L et al.. 2021. The cancer metabolic reprogramming and immune response.. Mol Cancer 20(1):28 PMID: 33546704
- 2. Ozga AJ et al.. 2021. Chemokines and the immune response to cancer.. Immunity 54(5):859-874 PMID: 33838745
- 3. Hill A et al.. 2021. Vaccine Delivery and Immune Response Basics.. Methods Mol Biol 2183:1-8 PMID: 32959236
- 4. Chen X et al.. 2018. Host Immune Response to Influenza A Virus Infection.. Front Immunol 9:320 PMID: 29556226
- 5. Traber KE et al.. 2025. The Integrated Pulmonary Immune Response to Pneumonia.. Annu Rev Immunol 43(1):545-569 PMID: 40036700
- 6. Kalluri R. 2024. The biology and function of extracellular vesicles in immune response and immunity.. Immunity 57(8):1752-1768 PMID: 39142276
- 7. Cáceres E et al.. 2024. Immune Response in Traumatic Brain Injury.. Curr Neurol Neurosci Rep 24(12):593-609 PMID: 39467990
- 8. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response.. Nature 449(7164):819-26 PMID: 17943118
